Vaginal Estrogen in Menopause: Dryness, Painful Sex, and Recurring UTIs

Vaginal dryness, burning, painful sex, and bladder symptoms can persist after menopause even when you have already tried lubricants, moisturizers, and drinking more water. Many patients also notice urinary tract infections that keep coming back. If that sounds familiar, low-dose vaginal estrogen is one of the options I offer in my practice, alongside non-hormonal moisturizers, pelvic floor support, and systemic HRT when hot flashes or sleep are part of the picture too.

In my practice at Tall Tree Cordova Bay and James Bay, vaginal estrogen is prescribed after a menopause consult where we look at your symptoms, history, and goals together. These symptoms are common and very treatable. Unlike hot flashes, which often ease with time, genitourinary symptoms tend to persist or slowly progress without care, so it is worth raising them rather than waiting them out.

So what is going on, exactly?

The tissues of the vulva, vagina, urethra, and bladder are rich in estrogen receptors. As estrogen falls through perimenopause and after menopause, those tissues become thinner, drier, and less elastic, and the healthy vaginal environment shifts.

The medical name for this cluster is genitourinary syndrome of menopause (GSM). It replaced the older term "vaginal atrophy" because it covers more than the vagina. Common symptoms include:

• Dryness, burning, itching, or irritation
• Pain or bleeding with sex
• Urinary urgency, frequency, or burning with urination
• Urinary tract infections that recur

The Menopause Society estimates GSM affects roughly 27% to 84% of postmenopausal women, depending on how it is measured. Many never mention it to a clinician, and many are never asked.

How vaginal estrogen helps

Low-dose vaginal estrogen puts a small amount of estrogen directly where the tissue needs it. It comes as a cream, a small vaginal tablet or insert, or a soft ring that slowly releases estrogen over several weeks. Your prescriber helps you choose a form and sets the schedule with you.

Because the dose is low and it works locally, very little reaches the rest of the body. Canada's obstetrics and gynaecology society (SOGC) notes that clinically significant absorption does not happen with low-dose vaginal therapy, so a separate progesterone is not needed to protect the uterus.

Many patients notice comfort improving over several weeks, with fuller benefit building over a few months. It works best used steadily, because the tissue changes return if it is stopped.

What the research actually shows

Vaginal estrogen has the strongest evidence base of any treatment for GSM. The 2025 guideline from the American Urological Association, written with two urogynecology societies and endorsed by The Menopause Society, gives it a strong recommendation for dryness, irritation, and painful sex.

For recurring UTIs, the same guideline goes a step further: clinicians should recommend low-dose vaginal estrogen to reduce the risk of future infections in postmenopausal patients with GSM. Canadian urology and gynaecology guidance points the same way.

On safety, one of the most reassuring data sets comes from the Nurses' Health Study. Researchers followed more than 53,000 postmenopausal women for 18 years and found that vaginal estrogen use was not linked to a higher risk of heart disease, stroke, blood clots, breast cancer, endometrial cancer, or hip fracture.

Moisturizers and lubricants still have a real place. Canadian guidance lists them as a first step, especially when dryness or painful sex is the only concern. A small 2026 trial also found that supervised pelvic floor training plus education eased urinary and sexual symptoms more than education alone, which makes pelvic floor work a useful partner to local treatment.

Is this a fit for you?

It may be a good conversation when:

• Dryness, irritation, or painful sex persist despite moisturizers and lubricants
• You have urinary urgency, burning, or UTIs that keep returning after menopause
• You are on systemic HRT for hot flashes or sleep and still have vaginal or bladder symptoms. Systemic estrogen does not always reach these tissues well enough on its own, and local therapy can be added

A consult decides whether it is right for you. Some situations need extra care or a different plan:

• Any unexplained vaginal bleeding after menopause needs to be assessed before starting treatment
• A personal history of breast cancer or another estrogen-sensitive cancer: this decision belongs with your oncology team. Post-cancer menopause care is outside my practice
• Symptoms that might have another cause, such as an infection, a skin condition, or a bladder issue, are worth sorting out first

What happens at the visit

Menopause consult (booked as a Naturopathic Consultation): we go through your symptoms, cycle and menopause history, current medications, and any prior treatments. We talk about whether local therapy alone makes sense, or whether systemic HRT belongs in the plan as well. If vaginal estrogen is a good fit, I prescribe it at that visit and walk you through how to use it.

Follow-up: we check how your symptoms are responding, adjust the form or schedule if needed, and decide together on long-term use. Pelvic floor physiotherapy is a good partner when urgency, leaking, or pain with sex are part of the picture.

Common questions

Is vaginal estrogen the same as HRT? They are related but not the same. Systemic HRT (an estradiol patch or gel, usually with oral progesterone) treats whole-body symptoms like hot flashes, night sweats, and sleep disruption. Vaginal estrogen is a low local dose aimed at the vulva, vagina, and bladder. Some patients need one, some need the other, and some do best with both.

Do I need progesterone with vaginal estrogen? With low-dose vaginal estrogen on its own, Canadian guidance says a separate progesterone is not needed, because so little is absorbed. If you are also using systemic estrogen and have a uterus, progesterone is still part of that systemic plan, and we will map that out together.

How long can I use it? For many patients it is a long-term treatment, because the tissue changes behind GSM tend to return when it stops. The long-term safety data so far are reassuring. We review how it is working at follow-ups and decide together on the right plan for you.

I read that estrogen has a warning label. Does that apply here? Much of the worry around estrogen traces back to research on higher-dose systemic hormones. The large Nurses' Health Study found no increase in heart disease, stroke, blood clots, or cancer with vaginal estrogen use. It is still a prescription medication, so we go through your personal history together before starting.

Can I just use a moisturizer instead? You can, and for mild dryness or occasional discomfort with sex that is often a good first step. Moisturizers ease symptoms but do not reverse the tissue changes underneath. When symptoms persist, or when bladder symptoms and UTIs are involved, vaginal estrogen is usually the more effective tool, and the two can be used together.

If dryness, painful sex, or recurring bladder symptoms are getting in the way of your life and you are in British Columbia, you are welcome to book a consult. We can sit down together and map whether vaginal estrogen, systemic HRT, or another approach is a good fit for you.

Perimenopause and menopause care (HRT) · Book at Tall Tree Cordova Bay · Book at Tall Tree James Bay

A precision practice.

Sources

1. The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. https://doi.org/10.1097/GME.0000000000001609
2. Kaufman MR, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 2025. https://doi.org/10.1097/JU.0000000000004589 · Guideline summary: https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopause
3. Society of Obstetricians and Gynaecologists of Canada. Guideline No. 422b: Menopause and Genitourinary Health. J Obstet Gynaecol Can. 2021. https://www.jogc.com/article/S1701-2163(21)00689-7/abstract
4. Canadian Urological Association. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. https://cuaj.ca/index.php/journal/article/download/687/490/2092
5. Bhupathiraju SN, et al. Vaginal estrogen use and chronic disease risk in the Nurses' Health Study. Menopause. 2019;26(6):603–610. https://doi.org/10.1097/GME.0000000000001284 · https://pmc.ncbi.nlm.nih.gov/articles/PMC6538478/
6. Supervised pelvic floor muscle training plus GSM education vs education alone in postmenopausal women: randomized controlled trial. Menopause. Published online 29 Sep 2026. https://doi.org/10.1097/GME.0000000000002914

Disclaimer

This content is general educational information, not medical advice, and not a substitute for individualized care from your own qualified provider. Dr. Sydney Green, ND provides clinical care only to patients within British Columbia.